This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a ceiling value of $2,361.84 and a completion date of December 27, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML medication. The contract is a firm fixed price agreement with a ceiling value of $1,022.56 and a completion date of September 5, 2024. There is no set-aside designation for this award. AmerisourceBergen, through its Corporate Office division, will be responsible for delivering the requested medication to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, and has a ceiling value of $1,064.68. The contract is a firm fixed-price delivery order, with a period of performance through February 19, 2025. This contract award is not associated with a set-aside program. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EMGALITY 120 MG/ML PENML medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) with a ceiling value of $1,671.20 and an ultimate completion date of August 9, 2024. The award does not have a set-aside designation. Amerisourcebergen, through its corporate office division, will provide the medication to...
This is a $1,671.20 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a prescription medication, to support federal healthcare requirements. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the supply of EMGALITY 120 MG/ML PENML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 2, 2024. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $1,002.72 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EMGALITY 120 MG/ML PENML, a medication. There is no set-aside designation for this contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the pharmaceutical product "EMGALITY 120 MG/ML PENML" and has a ceiling value of $1,800. The contract is a Firm Fixed Price agreement with an ultimate completion date of January 29, 2025. This Delivery Order is under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has a firm fixed price of $1,069.80 and a period of performance through July 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty medications, generic drugs, vaccines, and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EMGALITY 120 MG/ML PENML, a medical product, with a ceiling value of $2,906.88 and a completion date of January 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...